Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harald Hefter

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Biomolecules|October 27, 2022
Cholinesterase Deficiency Syndrome-A Pitfall in the Use of Butyrylcholinesterase as a Biomarker for Wilson's DiseaseMax Arslan, Max Novak, Dietmar Rosenthal, et al.
Toxins|August 8, 2020
Clinical Implications of Difference in Antigenicity of Different Botulinum Neurotoxin Type A Preparations: Clinical Take-Home Messages from Our Research Pool and LiteratureSara Samadzadeh, Beyza Ürer, Raphaela Brauns, et al.
Toxins|July 28, 2023
Lessons about Botulinum Toxin A Therapy from Cervical Dystonia Patients Drawing the Course of Disease: A Pilot StudyHarald Hefter, Isabelle Schomaecker, Max Schomaecker, et al.
Journal of Neurology|January 29, 2005
Is levodopa toxic?Thomas Müller, Harald Hefter, Roland Hueber, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Postural tremor in Wilson's disease: a magnetoencephalographic studyMartin Südmeyer, Bettina Pollok, Harald Hefter, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 23, 2006
Synchronized brain network underlying postural tremor in Wilson's diseaseMartin Südmeyer, Bettina Pollok, Harald Hefter, et al.
Neurology|October 23, 2019
Author response: High prevalence of neutralizing antibodies after long-term botulinum neurotoxin therapyPhilipp Albrecht, Alexander Jansen, John-Ih Lee, et al.
Toxins|January 20, 2022
Significant Long-Lasting Improvement after Switch to Incobotulinum Toxin in Cervical Dystonia Patients with Secondary Treatment FailureHarald Hefter, Beyza Ürer, Raphaela Brauns, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 18, 2006
Wilson's disease tremor is associated with magnetic resonance imaging lesions in basal ganglia structuresMartin Südmeyer, Andreas Saleh, Lars Wojtecki, et al.
Neurology|October 23, 2019
Author response: High prevalence of neutralizing antibodies after long-term botulinum neurotoxin therapyPhilipp Albrecht, Alexander Jansen, John-Ih Lee, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Biomolecules|October 27, 2022
Cholinesterase Deficiency Syndrome-A Pitfall in the Use of Butyrylcholinesterase as a Biomarker for Wilson's DiseaseMax Arslan, Max Novak, Dietmar Rosenthal, et al.
Toxins|August 8, 2020
Clinical Implications of Difference in Antigenicity of Different Botulinum Neurotoxin Type A Preparations: Clinical Take-Home Messages from Our Research Pool and LiteratureSara Samadzadeh, Beyza Ürer, Raphaela Brauns, et al.
Toxins|July 28, 2023
Lessons about Botulinum Toxin A Therapy from Cervical Dystonia Patients Drawing the Course of Disease: A Pilot StudyHarald Hefter, Isabelle Schomaecker, Max Schomaecker, et al.
Journal of Neurology|January 29, 2005
Is levodopa toxic?Thomas Müller, Harald Hefter, Roland Hueber, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Postural tremor in Wilson's disease: a magnetoencephalographic studyMartin Südmeyer, Bettina Pollok, Harald Hefter, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 23, 2006
Synchronized brain network underlying postural tremor in Wilson's diseaseMartin Südmeyer, Bettina Pollok, Harald Hefter, et al.
Neurology|October 23, 2019
Author response: High prevalence of neutralizing antibodies after long-term botulinum neurotoxin therapyPhilipp Albrecht, Alexander Jansen, John-Ih Lee, et al.
Toxins|January 20, 2022
Significant Long-Lasting Improvement after Switch to Incobotulinum Toxin in Cervical Dystonia Patients with Secondary Treatment FailureHarald Hefter, Beyza Ürer, Raphaela Brauns, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 18, 2006
Wilson's disease tremor is associated with magnetic resonance imaging lesions in basal ganglia structuresMartin Südmeyer, Andreas Saleh, Lars Wojtecki, et al.
Neurology|October 23, 2019
Author response: High prevalence of neutralizing antibodies after long-term botulinum neurotoxin therapyPhilipp Albrecht, Alexander Jansen, John-Ih Lee, et al.
Pageof 8